FDA Accepts Supplemental New Drug Application for Pfizer's XALKORI® for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma Pharmaceutical Investing
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate Medical Device Investing
Lexaria Receives Orders for 4.4 Million Servings of DehydraTECH-Enabled CBD Powders Biotech Investing
Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts Pharmaceutical Investing
Medtronic Receives FDA "Breakthrough Device Designation" for TYRX Driveline Wrap Device Medical Device Investing
Algernon Announces 50% Enrollment in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation Medical Device Investing
Better Plant Sciences Announces JUSU Juices Now Available for Home Delivery in Victoria Cannabis Investing News
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel Biotech Investing
